Meet the stakeholders at eyeforpharma’s 4th annual Oncology Europe Summit Build a complimentary clinical and market access strategies by meeting the decision makers that shape the future of oncology. The agenda includes knowledge of NICE, NHS, IQWIG, AETS, AIFA, and other payors/regulators across Europe. Speakers include • Andrea Rappagliosi (VP, GSK) • Bruno Osterwalder (SVP, Merck Serono) • Omar Ali (Cost Modelling and Formulary Development Advisor, NICE/NHS) • Charalabos-Markos Dintsios (Former Deputy Head, Departments of Health Economics, IQWIG, now VfA) The topics they’ll cover include: • German healthcare reform and new IQWIG oncology endpoint guidelines • Cancer drugs fund, patient access schemes and value-based pricing in an oncology context • Risk-sharing schemes and how they affect oncology access • Building multiple stakeholder requirements into your evidence generation strategy To download the full brochure click here – www.eyeforpharma.com/oncology